MONTREAL--(BUSINESS WIRE)--KLOX Technologies Inc. (“KLOX”) announced today that Dr. Lise Hébert, President and Chief Executive Officer, will be presenting at the Biotech Showcase™ 2013 Investor and Partnering Conference this Tuesday, January 8, at 9:00 a.m. (PST) in San Francisco, California.
Investors, media and other interested individuals will be able to consult the presentation through the Investor Relations section of the company’s corporate website at www.kloxtechnologies.com the same day.
About Biotech Showcase™ 2013
Biotech Showcase™ is an investor and partnering conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the course of one of the industry's largest annual healthcare investor conferences. Investors and biopharmaceutical executives from around the world gather in San Francisco during this critical week, which is widely viewed as setting the tone for the coming year. For more information, please visit www.ebdgroup.com/bts.
About KLOX Technologies: Leveraging light-based biophotonic technologies
KLOX is a privately-owned company focused on the development and commercialization of a unique, non-invasive biophotonic technology using a primary device consisting of a multiple LED lighting system that interacts with an oxygen-rich gel containing light-trapping molecules. KLOX's cosmetics and medical devices are destined for the rapidly growing aesthetics, dental, dermatological and medical markets. Its dentistry portfolio included innovative teeth whitening treatments like FAST&MILD™ and LifeSmile™. Treatments for periodontitis are also currently under development for medical applications.